Literature DB >> 8370182

Induction of immune-mediated glomerulonephritis in normal mice immunized with bacterial DNA.

G S Gilkeson1, P Ruiz, D Howell, J B Lefkowith, D S Pisetsky.   

Abstract

Normal mice immunized with bacterial DNA produce high titers of anti-DNA antibodies and represent a new model for autoantibody production in systemic lupus erythematosus. To determine whether DNA immunization can also provoke clinical manifestations of lupus, the occurrence of nephritis in immunized mice was assessed and correlated with levels of anti-DNA as well as antibodies to glomerular antigens. BALB/c mice immunized with Escherichia coli single-stranded DNA in complexes with methylated bovine serum albumin in adjuvant showed increased proteinuria compared to control mice immunized with mBSA alone. Furthermore, DNA immunized mice had significantly greater glomerular proliferative changes and immunoglobulin deposition than control mice. In an in vitro assay, sera from DNA immunized mice exhibited greater binding to glomerular antigens than sera from control mice. Compared to sera, renal eluates from DNA-immunized mice were enriched for anti-DNA and glomerular binding activity. These data indicate that immunization of normal mice with E. coli DNA induces an immune-mediated proliferative glomerulonephritis that is likely secondary to the renal deposition of anti-DNA antibodies.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8370182     DOI: 10.1006/clin.1993.1129

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  13 in total

Review 1.  Activation of the innate immune system by CpG oligodeoxynucleotides: immunoprotective activity and safety.

Authors:  D M Klinman; S Kamstrup; D Verthelyi; I Gursel; K J Ishii; F Takeshita; M Gursel
Journal:  Springer Semin Immunopathol       Date:  2000

2.  Is there a link between Escherichia coli septicemia and the onset of systemic lupus erythematosus? Comment on: overlapping juvenile idiopathic arthritis and systemic lupus erythematosus: a case report (Rheumatol Int. 2011 May; 31(5):695-698).

Authors:  Se Jin Park; Ji Hong Kim; Tae Sun Ha; Jae Il Shin
Journal:  Rheumatol Int       Date:  2011-11-16       Impact factor: 2.631

Review 3.  The pathogenesis and diagnosis of systemic lupus erythematosus: still not resolved.

Authors:  Ole Petter Rekvig; Johan Van der Vlag
Journal:  Semin Immunopathol       Date:  2014-04-25       Impact factor: 9.623

Review 4.  DNA vaccines: safety and efficacy issues.

Authors:  D M Klinman; M Takeno; M Ichino; M Gu; G Yamshchikov; G Mor; J Conover
Journal:  Springer Semin Immunopathol       Date:  1997

Review 5.  CpG DNA as a vaccine adjuvant.

Authors:  Christian Bode; Gan Zhao; Folkert Steinhagen; Takeshi Kinjo; Dennis M Klinman
Journal:  Expert Rev Vaccines       Date:  2011-04       Impact factor: 5.217

Review 6.  Anti-dsDNA antibodies as a classification criterion and a diagnostic marker for systemic lupus erythematosus: critical remarks.

Authors:  O P Rekvig
Journal:  Clin Exp Immunol       Date:  2015-01       Impact factor: 4.330

Review 7.  Recent progress concerning CpG DNA and its use as a vaccine adjuvant.

Authors:  Hidekazu Shirota; Dennis M Klinman
Journal:  Expert Rev Vaccines       Date:  2013-11-26       Impact factor: 5.217

Review 8.  Lupus nephritis: the central role of nucleosomes revealed.

Authors:  Elin S Mortensen; Kristin A Fenton; Ole P Rekvig
Journal:  Am J Pathol       Date:  2008-01-10       Impact factor: 4.307

9.  Modulation of renal disease in autoimmune NZB/NZW mice by immunization with bacterial DNA.

Authors:  G S Gilkeson; P Ruiz; A M Pippen; A L Alexander; J B Lefkowith; D S Pisetsky
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

10.  Role of Structure-Based Changes due to Somatic Mutation in Highly Homologous DNA-Binding and DNA-Hydrolyzing Autoantibodies Exemplified by A23P Substitution in the VH Domain.

Authors:  A V Kozyr; A V Kolesnikov; A E Khlyntseva; A G Bogun; G A Savchenko; I G Shemyakin; A G Gabibov
Journal:  Autoimmune Dis       Date:  2012-11-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.